Prognostic Disclosure Associated With Improved Understanding of End-of-Life Care
the ONA take:
A multicenter observational study sought to determine how prognostic conversations influence perception of life expectancy, distress, and the patient-physician relationship among patients with advanced cancer.
The study included a cohort of 590 patients with advanced cancer who were asked whether their oncologist disclosed an estimate of prognosis.
They were also asked to estimate their own life expectancy and complete assessments of the patient-physician relationship, distress, advance directives, and end-of-life care preferences.
The researchers found that 71% of patients wanted to know their life expectancy, but only 17.6% recalled their physician disclosing a prognosis; 51% were willing to estimate their own life expectancy.
Those patients who recalled a prognostic disclosure provided more realistic estimates of life expectancy compared with those who did not. In addition, their estimates were less likely to differ from their actual survival.
Patients who recalled prognostic disclosure provided an estimated life expectancy that was decreased by 17.2 months compared with those who did not recall prognostic disclosure.
Longer self-estimates of life expectancy were associated with lower likelihood of do-not-resuscitate orders and preference for life-prolonging over comfort-oriented care.
Prognostic disclosure was not associated with worse patient-physician relationship ratings, and sadness or anxiety were not increased in these patients.
How prognostic conversations influence perception of life expectancy, distress, and the patient-physician relationship among patients with advanced cancer.
- Physical Activity Improves Outcomes for Patients with Breast Cancer and Survivors
- Whole Genome Sequencing Reveals that 12% of Childhood Cancer Survivors Have Mutations in Genes that Increase Cancer Risk
- Behavior Pain Assessment Tool Measures Pain In Patients Who Cannot Communicate Verbally
- Increased 5-Year Survival Rate Seen in NSCLC Subset Treated With Nivolumab
- Novel Test For Multiple Myeloma Uses Microchip, Conventional Blood Sample
- Exercise, Psychological Interventions Better for Cancer Fatigue Than Medications
- ASCO Issues Global Guidance for HPV Vaccination for Cervical Cancer Prevention
- Discharge Events Improved With Standardized Inpatient Palliative Care Consultation
- Little Opposition to Early Palliative Care for Symptom Management in Pediatric Oncology
- Mammograms (Fact Sheet)
- Shifts in Cancer Burden for People With HIV Projected
- Tissue Biobank Procurement Consent Should Include Discussion of Confidentiality Risks
- Health Care Expansion Tied to Increased Rates of Surgical Treatment of Thyroid Cancer
- Thyroid Cancer Incidence Increasing Among Younger, Hispanic, African American Populations
- JAK1, JAK2 Inhibition Improves Outcomes in Myeloproliferative Neoplasms, But More Is Needed
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|